Prof. Dr.med. Hans Rickli
chief physician
Kardiologie · Dept. I
Differential Prognostic Impact of Resting Heart Rate in Older Compared to Younger Patients with Chronic Heart Failure - Insights from TIME-CHF
Zurek M, Brunner-La Rocca H, Pfisterer M, Jeker U, Handschin R, Abbühl H, Sanders-van Wijk S, Muzzarelli S, Rickli H, Maeder M, TIME-CHF Investigators. Differential Prognostic Impact of Resting Heart Rate in Older Compared to Younger Patients with Chronic Heart Failure - Insights from TIME-CHF. J Card Fail 2015
Jan 7, 2015Differential Prognostic Impact of Resting Heart Rate in Older Compared to Younger Patients with Chronic Heart Failure - Insights from TIME-CHF
Jan 7, 2015J Card Fail 2015
Zurek Marzena, Brunner-La Rocca Hans-Peter, Pfisterer Matthias, Jeker Urs, Handschin Rolf, Abbühl Heidi, Sanders-van Wijk Sandra, Muzzarelli Stefano, Rickli Hans, Maeder Micha, TIME-CHF Investigators
Giant biventricular thrombi in a patient with heart failure and heparin-induced thrombocytopenia
Rigger J, Ehl N, Nägele R, Rickli H, Maeder M. Giant biventricular thrombi in a patient with heart failure and heparin-induced thrombocytopenia. Int J Cardiol 2015; 182C:377-378.
Jan 3, 2015Giant biventricular thrombi in a patient with heart failure and heparin-induced thrombocytopenia
Jan 3, 2015Int J Cardiol 2015; 182C:377-378
Rigger Johannes, Ehl Niklas, Nägele Reto, Rickli Hans, Maeder Micha
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
Kaiser C, Vuillomenet A, Steiner M, von Felten S, Vogt D, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M, Weilenmann D, Rickli H, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz D, Pedrazzini G, Moccetti T, BASKET-PROVE II study group. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 2014; 131:74-81.
Nov 19, 2014Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
Nov 19, 2014Circulation 2014; 131:74-81
Kaiser Christoph, Vuillomenet André, Steiner Martin, von Felten Stefanie, Vogt Deborah R, Wadt Hansen Kim, Rickenbacher Peter, Conen David, Müller Christian, Buser Peter, Hoffmann Andreas, Pfisterer Matthias, Weilenmann Daniel, Rickli Hans, Galatius Soeren, Jeger Raban, Gilgen Nicole, Skov Jensen Jan, Naber Christoph, Alber Hannes, Wanitschek Maria, Eberli Franz, Kurz David J, Pedrazzini Giovanni, Moccetti Tiziano, BASKET-PROVE II study group
Comprehensive biomarker profiling in patients with obstructive sleep apnea
Maeder M, Rickli H, Twerenbold R, Brutsche M, Hilti J, Thalmann G, Wildi K, Estis J, Todd J, Christ M, Strobel W, Mueller C. Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem 2014
Sep 16, 2014Comprehensive biomarker profiling in patients with obstructive sleep apnea
Sep 16, 2014Clin Biochem 2014
Maeder Micha, Rickli Hans, Twerenbold Raphael, Brutsche Martin, Hilti Jonas, Thalmann Gregor, Wildi Karin, Estis Joel, Todd John, Christ Michael, Strobel Werner, Mueller Christian
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
Jeger R, Kaiser C, Galatius S, Rickli H, Pedrazzini G, Erne P, Eberli F, Bonetti P, Alber H, von Felten S, Sørensen R, Pfisterer M, BASKET and BASKET-PROVE investigators. Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. Am Heart J 2014; 168:698-705.
Jul 30, 2014Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
Jul 30, 2014Am Heart J 2014; 168:698-705
Jeger Raban V, Kaiser Christoph A, Galatius Søren, Rickli Hans, Pedrazzini Giovanni, Erne Paul, Eberli Franz, Bonetti Piero O, Alber Hannes, von Felten Stefanie, Sørensen Rikke, Pfisterer Matthias E, BASKET and BASKET-PROVE investigators
"Double takotsubo": first description of the sequence of classical followed by inverted type in a young woman
Ehl N, Zurek M, Rickli H, Maeder M. "Double takotsubo": first description of the sequence of classical followed by inverted type in a young woman. Int J Cardiol 2014; 174:e36-7.
Apr 16, 2014"Double takotsubo": first description of the sequence of classical followed by inverted type in a young woman
Apr 16, 2014Int J Cardiol 2014; 174:e36-7
Ehl Niklas, Zurek Marzena, Rickli Hans, Maeder Micha
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus
Wuerzner G, Pechère-Bertschi A, Baumgartner I, Jacob A, Burnier M, Qanadli S, Swiss Society of Hypertension, Swiss Society of Cardiology, Swiss Society of Angiology, Sticherling C, Kaiser C, Waeber B, Muller O, Erne P, Cook S, Sudano I, Lüscher T, Noll G, Kaufmann U, Rickli H, Swiss Society of Cardiovascular and Interventional Radiology. Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus. Swiss Med Wkly 2014; 144:w13913.
Mar 20, 2014Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus
Mar 20, 2014Swiss Med Wkly 2014; 144:w13913
Wuerzner Gregoire, Pechère-Bertschi Antoinette, Baumgartner Iris, Jacob Augustinus L, Burnier Michel, Qanadli Salah D, Swiss Society of Hypertension, Swiss Society of Cardiology, Swiss Society of Angiology, Sticherling Christian, Kaiser Christophe, Waeber Bernard, Muller Olivier, Erne Paul, Cook Stéphane, Sudano Isabella, Lüscher Thomas F, Noll Georg, Kaufmann Urs, Rickli Hans, Swiss Society of Cardiovascular and Interventional Radiology
Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide
Zurek M, Maeder M, Brutsche M, Lüthi A, Twerenbold R, Freese M, Rickli H, Mueller C. Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide. Eur J Appl Physiol 2014; 114:815-24.
Jan 5, 2014Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide
Jan 5, 2014Eur J Appl Physiol 2014; 114:815-24
Zurek Marzena, Maeder Micha, Brutsche Martin, Lüthi Adrian, Twerenbold Raphael, Freese Michael, Rickli Hans, Mueller Christian
Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF
Sanders-van Wijk S, Brunner-La Rocca H, Pfisterer M, Peter M, Rickenbacher P, Erne P, Estlinbaum W, Rickli H, Nietlispach F, Maeder M, TIME-CHF Investigators. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Circ Heart Fail 2013; 7:131-9.
Dec 18, 2013Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF
Dec 18, 2013Circ Heart Fail 2013; 7:131-9
Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter, Pfisterer Matthias P, Peter Martin, Rickenbacher Peter, Erne Paul, Estlinbaum Werner, Rickli Hans, Nietlispach Fabian, Maeder Micha, TIME-CHF Investigators
Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012
Radovanovic D, Seifert B, Urban P, Eberli F, Rickli H, Bertel O, Puhan M, Erne P, AMIS Plus Investigators. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart 2013; 100:288-94.
Nov 1, 2013Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012
Nov 1, 2013Heart 2013; 100:288-94
Radovanovic Dragana, Seifert Burkhardt, Urban Philip, Eberli Franz R, Rickli Hans, Bertel Osmund, Puhan Milo A, Erne Paul, AMIS Plus Investigators
[Heart failure with preserved left ventricular ejection fraction]
Maeder M, Rickli H. [Heart failure with preserved left ventricular ejection fraction]. Praxis (Bern 1994) 2013; 102:1299-307.
Oct 16, 2013[Heart failure with preserved left ventricular ejection fraction]
Oct 16, 2013Praxis (Bern 1994) 2013; 102:1299-307
Maeder Micha, Rickli Hans
Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure
Burkard T, Brunner-La Rocca H, Pfisterer M, Handschin R, Pittl U, Zaker R, Hack D, Follath F, Rickli H, Pfister O, TIME-CHF Investigators. Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure. QJM 2013; 107:131-8.
Oct 15, 2013Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure
Oct 15, 2013QJM 2013; 107:131-8
Burkard T, Brunner-La Rocca H-P, Pfisterer M, Handschin R, Pittl U, Zaker R, Hack D, Follath F, Rickli Hans, Pfister O, TIME-CHF Investigators
Prevalence of severely impaired left ventricular ejection fraction after reperfused ST-elevation myocardial infarction
Altmann D, Osswald S, Rickli H, Kühne M, Ammann P, Jörg L, Schär B, Koller M, Ehl N, Mutschelknauss M, Sticherling C. Prevalence of severely impaired left ventricular ejection fraction after reperfused ST-elevation myocardial infarction. Swiss Med Wkly 2013; 143:w13869.
Sep 6, 2013Prevalence of severely impaired left ventricular ejection fraction after reperfused ST-elevation myocardial infarction
Sep 6, 2013Swiss Med Wkly 2013; 143:w13869
Altmann D, Osswald S, Rickli Hans, Kühne M, Ammann P, Jörg L, Schär B, Koller M, Ehl Niklas, Mutschelknauss M, Sticherling C
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial
Jensen M, Galatius S, Pfisterer M, Erne P, De Servi S, Bertel O, Fahrni G, Zurek M, Rickli H, Soerensen R, Pedersen S, Jensen J, Iversen A, Wanitschek M, Alber H, Sandsten K, Kaiser C, BASKET-PROVE Investigators. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial. Int J Cardiol 2013; 168:3802-6.
Jul 11, 2013Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial
Jul 11, 2013Int J Cardiol 2013; 168:3802-6
Jensen Magnus Thorsten, Galatius Søren, Pfisterer Matthias, Erne Paul, De Servi Stefano, Bertel Osmund, Fahrni Gregor, Zurek Marzena, Rickli Hans, Soerensen Rikke, Pedersen Sune, Jensen Jan Skov, Iversen Allan, Wanitschek Maria, Alber Hannes, Sandsten Karl Erik, Kaiser Christoph, BASKET-PROVE Investigators
[Measuring self care of patients with heart failure]
Cattilaz-Langenauer V, Rickli H, Hantikainen V, Lohrmann C, Dassen T, Köberich S. [Measuring self care of patients with heart failure]. Pflege Z 2013; 66:356-60.
Jun 1, 2013[Measuring self care of patients with heart failure]
Jun 1, 2013Pflege Z 2013; 66:356-60
Cattilaz-Langenauer Verena, Rickli Hans, Hantikainen Virpi S, Lohrmann Christa, Dassen Theo, Köberich Stefan
N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF)
Maeder M, Brunner-La Rocca H, Pfisterer M, Peter M, Vuilliomenet A, Erne P, Gutmann M, Abbühl H, Rickli H, Rickenbacher P, TIME-CHF Investigators. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Eur J Heart Fail 2013; 15:1148-56.
May 8, 2013N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF)
May 8, 2013Eur J Heart Fail 2013; 15:1148-56
Maeder Micha, Brunner-La Rocca Hans-Peter, Pfisterer Matthias, Peter Martin, Vuilliomenet André, Erne Paul, Gutmann Marc, Abbühl Heidi, Rickli Hans, Rickenbacher Peter, TIME-CHF Investigators
Left ventricular apical thrombus many months after pericardial biopsy
Ehl N, Rohner F, Maeder M, Rickli H. Left ventricular apical thrombus many months after pericardial biopsy. Cardiovascular Medicine 2013; 16:132-133.
Apr 18, 2013Left ventricular apical thrombus many months after pericardial biopsy
Apr 18, 2013Cardiovascular Medicine 2013; 16:132-133
Ehl Niklas, Rohner Franziska, Maeder Micha, Rickli Hans
Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
Sanders-van Wijk S, Brunner-La Rocca H, Pfisterer M, Peter M, Vuillomenet A, Rickenbacher P, Erne P, Estlinbaum W, Rickli H, van Asselt A, TIME-CHF Investigators. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). JACC Heart Fail 2013; 1:64-71.
Feb 4, 2013Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)
Feb 4, 2013JACC Heart Fail 2013; 1:64-71
Sanders-van Wijk Sandra, Brunner-La Rocca Hans-Peter, Pfisterer Matthias E, Peter Martin, Vuillomenet André, Rickenbacher Peter, Erne Paul, Estlinbaum Werner, Rickli Hans, van Asselt Antoinette D I, TIME-CHF Investigators
Acute eosinophilic myocarditis with dramatic response to steroid therapy: the central role of echocardiography in diagnosis and follow-up
Eppenberger M, Hack D, Ammann P, Rickli H, Maeder M. Acute eosinophilic myocarditis with dramatic response to steroid therapy: the central role of echocardiography in diagnosis and follow-up. Tex Heart Inst J 2013; 40:326-30.
Jan 1, 2013Acute eosinophilic myocarditis with dramatic response to steroid therapy: the central role of echocardiography in diagnosis and follow-up
Jan 1, 2013Tex Heart Inst J 2013; 40:326-30
Eppenberger Manuela, Hack Dietrich, Ammann Peter, Rickli Hans, Maeder Micha
Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?
Zurek M, Maeder M, Brutsche M, Christ A, Bosshard P, Ziller R, Rickli H, Kaye D, Mueller C. Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?. Int J Cardiol 2012
Nov 22, 2012Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?
Nov 22, 2012Int J Cardiol 2012
Zurek Marzena, Maeder Micha, Brutsche Martin H, Christ Andreas, Bosshard Piet, Ziller Ronny, Rickli Hans, Kaye David M, Mueller Christian